News thumbnail
Health / Mon, 20 Jul 2026 Nature

Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias - Nature

Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias NatureBlood Test May Predict Future Risk of Cognitive Impairment in Alzheimer's Disease: JAMA Medical DialoguesNew Alzheimer’s blood test may be promising but is not yet ready for widespread use CNNAlzheimer’s Blood Tests Offer New Promise to Diagnose and Predict the Disease The New York TimesBuilding the Foundation for Earlier Alzheimer Disease Diagnosis NeurologyLive

Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias NatureBlood Test May Predict Future Risk of Cognitive Impairment in Alzheimer's Disease: JAMA Medical DialoguesNew Alzheimer’s blood test may be promising but is not yet ready for widespread use CNNAlzheimer’s Blood Tests Offer New Promise to Diagnose and Predict the Disease The New York TimesBuilding the Foundation for Earlier Alzheimer Disease Diagnosis NeurologyLive

© All Rights Reserved.